Trial Profile
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial of PROSCAR in Men With Initial Negative Prostate Biopsies.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Finasteride (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- Acronyms Prostress
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2011 Planned End Date changed from 1 Jan 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.